Jasper Hellweg analyst ARGUS

Currently out of the existing stock ratings of Jasper Hellweg, 143 are a BUY (87.2%), 21 are a HOLD (12.8%).

Jasper Hellweg

Work Performance Price Targets & Ratings Chart

Analyst Jasper Hellweg, currently employed at ARGUS, has had 73.42% of price targets met with an average potential upside of 15.07%, reached in 237 days on average.

Jasper Hellweg has documented 309 price targets and ratings displayed on 39 stocks. The coverage is on Healthcare, Industrials, Technology, Consumer Cyclical, Basic Materials sectors.

Most recent stock forecast was given on AMGN, Amgen at 12-Nov-2026.

Wall Street Analyst Jasper Hellweg

Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) on 11/11/2020. The price target of $88 was fulfilled within 2 days with a profit of $5.56 (6.74%), with a performance score of 33.72.

Average potential price target upside

ANTM Anthem ILMN Illumina MDRX Allscripts Healthcare Solutions MRNA Moderna REGN Regeneron Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis CERN Cerner Corp IQV IQVIA Holdings ITGR Integer Holdings Corp LH Laboratory of America Holdings VRTX Vertex Pharmaceuticals HCA HCA Holdings ELV Elevance Health GILD Gilead Sciences UTHR United Therapeutics ABBV AbbVie AZN AstraZeneca PLC ADR BIIB Biogen BSX Boston Scientific Corp INCY yte NVO Novo Nordisk A/S SNY Sanofi ADR DGX Quest Diagnostics EBS Emergent Biosolutions EFX Equifax FISV Fiserv LGND Ligand Pharmaceuticals MYL Viatris VTRS Viatris BAX Baxter International PRGO Perrigo Company PLC AMGN Amgen AN AutoNation CE Celanese BMY Bristol-Myers Squibb Company FI Fiserv MRK Merck mpany LLY Eli Lilly and Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Jul-2021

$617

4 years 4 months 30 days ago
(22-Jun-2022)

4/6 (66.67%)

$95.47 (18.31%)

149

Buy Since 17-Jun-2022

$550

4 years 5 months 4 days ago
(17-Jun-2022)

0/1 (0%)

$95.24 (20.94%)

Buy Since 27-Apr-2017

$596

$574

4 years 5 months 25 days ago
(27-May-2022)

3/5 (60%)

$76.79 (14.79%)

741

Buy Since 19-May-2021

$580

$500

4 years 5 months 27 days ago
(25-May-2022)

3/4 (75%)

$76.52 (15.20%)

177

Buy Since 01-Nov-2018

$625

$510

4 years 6 months 27 days ago
(25-Apr-2022)

5/6 (83.33%)

$119.43 (23.62%)

427

Show more analysts

Please expand the browser size to see the chart

Which stock is Jasper Hellweg most bullish on?

Potential upside of $202.89 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Jasper Hellweg most reserved on?

Potential downside of -$70.69 has been obtained for REGN (REGENERON PHARMACEUTICALS)

What Year was the first public recommendation made by Jasper Hellweg?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?